Feb/08/2010 03:22 Filed in:
Really
bad DTC #in
26,000 lawsuits,
the word "fatal" used in side effects and Astra
Zeneca is doing TV ads for Seroquel XR ? Let's be
clear about this product, it's a major drug with
serious side effects for very serious conditions.
Does AZ really believe that people are going to go
into their physician and ask for Seroquel XR
? Read
More...
Tags: Seroquel
Feb/08/2010 09:30 Filed in:
#epharma
#in
Another barrier to
social media use by pharma? The FDA expects drug
advertisements to use the same level of language to
convey both safety and efficacy information,
according to a pair of letters from the Division of
Drug Marketing, Advertising and Communications. In
both a Jan. 26 letter regarding Meda's Astelin and
a Jan. 22 letter for Novalar's OraVerse , FDA's ad
enforcement division took issue with the use of
user-friendly language for the efficacy claims
while the risk information was presented using
less-clear scientific terminology. Even if it's
easier to understand for consumers and
patients. Read
More...
Tags: Content
Feb/08/2010 06:14 Filed in:
Technology
& Healthcare #in
I had an
interesting Twitter conversation last week about
the quality of online health information. Late last
year we recruited an online panel to review health
information for 3 months and while a program
monitored their Internet usage. We then followed up
with some surveys to try an gauge the "quality" of
online health information and the "experience" of
their searches. Here are the results...
Read
More...
Tags: Online health
Feb/06/2010 07:06 Filed in:
Technology
& Healthcare
This week,
Epocrates Inc., the developer of mobile
applications used by more than 900,000 healthcare
professionals worldwide, revealed a new study of
more than 350 clinicians conducted in the wake of
Apple's iPad announcement. Among those surveyed, 9%
said they plan to buy an iPad when it is
immediately available, and another 13% intend to
purchase one in the first year. A lot of people are
asking if the iPad is truly the future of DTC
marketing and health. Here are some things to
remember. Read
More...
Tags: iPad #in
A new tax on
profits from some patents and other intangible
assets parked in overseas tax havens by American
companies. That was the land mine in President
Obama's budget this week. The drug industry giant
Pfizer which has said that 88% of its $56 billion
in income from 2004 through 2008 originated
overseas, could be subject to the corporate 35% tax
rate on at least some of its foreign profit in the
future if the president’s proposal goes
through. Read
More...
Tags: Off-shore
Feb/04/2010 04:03 Filed in:
Business
of health #in
GlaxoSmithKline
said it will stop research into new antidepressants
and focus on diseases for which it believes it can
develop more valuable drugs, a major shift for a
company that developed some of the biggest-selling
antidepressants of the past 20 years. The key
question is "valuable to who" , investors or
patients ? Maybe the reason is because physicians
and patients are buying the marketing that led to a
lot of people taking antidepressant medications ?
Read
More...
Tags: GSK
Feb/04/2010 10:25 Filed in:
FDA
Letters
And you thought
Cialis was just for men with ED. Adcirca (Cialis
40mg) just received a letter from the FDA
for
omitting key risk information from their website
and for misleading patient videos. United
Therapeutics licensed the rights to develop,
market, promote and commercialize Adcirca for
pulmonary hypertension in the United States and
Puerto Rico from Eli Lilly & Company in
November 2008. Read
More...
Tags: Adcica
Feb/04/2010 07:04 Filed in:
Healthcare
in the US #in
In a stark
reminder of growing costs, the government has
released a new estimate that healthcare spending
grew to a record 17.3% of the U.S. economy last
year, marking the largest one-year jump in its
share of the economy since the government started
keeping such records half a century ago. The U.S.
spent $2.472 trillion on health care last year,
according to a paper out today in the journal
Health Affairs. That’s $282 million an hour. In the
meantime Pfizer said it sees R&D spending
falling to between $8 billion and $8.5 billion by
2012 or over $1 billion. Read
More...
Tags: US Healthcare
If you Google
Toyota, among the first things that pop up is an ad
slugged "Toyota Recall News". In the meantime
AstraZeneca is facing as many as 26,000 lawsuits
over its antipsychotic drug Seroquel as the
drugmaker prepares for its first jury trial over
claims the medicine causes diabetes, according to
court filings. What is so puzzling here is that the
some companies continue to make the same mistakes
over and over and don't understand that consumers
have more information than they do.
Read
More...
Tags: Lack of Transparency
Do you think
consumers and patients are really ready to share
all their personal information via social media ?
Think again. The research that we conducted last
year showed that users of social media for health
do not want others knowing they have been there and
that is a key reason they would not follow a brand
or health condition online.
Read
More...
Tags: Facebook
Feb/02/2010 05:49 Filed in:
#socialmedia
#in
Twitter is locking
many users out of the system this morning, and
sending them notices that they need to change their
passwords in order to regain access to the service,
due to concerns over a possible phishing attack.
70% of Facebook users are outside the US and growth
is continuing to come from outside the US. So at a
time when a LOT of people think social media can
save the drug industry one has to wonder if in fact
social media is ready for the drug industry ?
Read
More...
Tags: Privacy & Social Media
Feb/01/2010 06:50 Filed in:
Working
in the drug industry
Novo Nordisk's
social mission is to "find a cure for diabetes".
How many drug companies can claim that their goal
is to cure the very disease that keeps them in
business ? In fact how many people really believe
that even if a drug company has a "social mission"
that they would follow it ?
Read
More...
Tags: Novo Nordisk
